Blood Neoplasia Oncology

Kinetic BCR::ABL1 reduction by transcript types in frontline CML treatment: a GIMEMA LabNet CML network survey

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →